Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children

We investigated the immunogenicity, seroprotection rates and persistence of immune memory in young children at high risk of pneumococcal disease in Papua New Guinea (PNG). Children were primed with 10-valent (PCV10) or 13-valent pneumococcal conjugate vaccines (PCV13) at 1, 2 and 3 months of age and...

Descrición completa

Detalles Bibliográficos

Principais autores:	Anita H. J. van den Biggelaar, William S. Pomat, Geraldine Masiria, Sandra Wana, Birunu Nivio, Jacinta Francis, Rebecca Ford, Megan Passey, Lea-Ann Kirkham, Peter Jacoby, Deborah Lehmann, Peter Richmond, the 10v13v PCV Trial Team
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2019-02-01
Series:	Vaccines
Assuntos:	pneumococcal polysaccharide vaccine pneumococcal conjugate vaccine <i>S. pneumoniae</i> antibodies immune memory Papua New Guinea
Acceso en liña:	https://www.mdpi.com/2076-393X/7/1/17
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!